azoxymethane has been researched along with 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, M; Guo, Q; Hu, R; Li, Z; Wang, Q; Wang, Y; Yang, X; Zhang, F | 1 |
1 other study(ies) available for azoxymethane and 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one
| Article | Year |
|---|---|
Oroxylin A inhibits colitis-associated carcinogenesis through modulating the IL-6/STAT3 signaling pathway.
Topics: Animals; Azoxymethane; Blotting, Western; Carcinogens; Cell Transformation, Neoplastic; Colitis; Colonic Neoplasms; Dextran Sulfate; Female; Flavonoids; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor | 2013 |